On Thursday, the company reported an 18% year-on-year increase in revenue for Q4 to Rs 1,182 crore, while operating EBITDA (excluding the Kasaragod facility) grew 31% to Rs 253 crore. Margins improved to 21.7% from 19.3% a year ago, supported by operating leverage and cost discipline. Normalised profit after tax increased 45% to Rs 153 crore, the company said in a press release.
On a proforma basis, including QCIL, the combined entity reported revenue of Rs 2,361 crore for the quarter, up 18%, while operating EBITDA rose 25% to Rs 517 crore, with margins at 21.9%.
Chairman Azad Moopen said the merger is on track for completion in the first quarter of FY27. “The overwhelming shareholder support, with 96.68% votes in favour, reflects strong confidence in our vision of building a scaled and integrated healthcare platform,” he said. “On a proforma basis, Q4 FY26 revenues grew 18% YoY… supported by strong growth in patient volumes, and continued margin expansion.”
The combined platform is expected to have over 10,600 beds across 28 cities, with a pipeline of more than 4,400 beds, positioning it among the top three healthcare providers in India.
Live Events
Operationally, growth was driven by higher patient volumes and improved realisations. Average revenue per inpatient rose 9% to Rs 1.25 lakh, while total patient volumes increased 15%.
Regionally, Kerala and Andhra Pradesh-Telangana clusters led growth.
The company said the merger, backed by investors including Blackstone, is pending final regulatory approvals and is expected to close in Q1 FY27, setting the stage for further scale and operational synergies.